Literature DB >> 8110179

Full activation of a nuclear species of protein phosphatase-1 by phosphorylation with protein kinase A and casein kinase-2.

A Van Eynde1, M Beullens, W Stalmans, M Bollen.   

Abstract

Bovine thymus nuclei contain a species of protein phosphatase-1 (PP-1N alpha) that can be partially activated by phosphorylation of an associated inhibitory polypeptide, NIPP-1, with protein kinase A [Beullens, Van Eynde, Bollen and Stalmans (1993) J. Biol. Chem. 268, 13172-13177]. Here it is shown that PP-1N alpha can also be activated 4-fold by phosphorylation of NIPP-1 with casein kinase-2. The effects of protein kinase A and casein kinase-2 were additive, yielding an enzyme with an activity close to that of the free catalytic subunit. Casein kinase-2 introduced up to 1.2 phosphate groups into purified NIPP-1 on serine and threonine residues. This phosphorylation was associated with a 14-fold increase in the concentration of NIPP-1 required for 50% inhibition of the type-1 catalytic subunit. The kinase-mediated inactivation of NIPP-1 could be reversed by incubation with the catalytic subunit of protein phosphatase-2A.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8110179      PMCID: PMC1137853          DOI: 10.1042/bj2970447

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  21 in total

1.  The isolation of novel inhibitory polypeptides of protein phosphatase 1 from bovine thymus nuclei.

Authors:  M Beullens; A Van Eynde; W Stalmans; M Bollen
Journal:  J Biol Chem       Date:  1992-08-15       Impact factor: 5.157

2.  Ser/Thr-specific protein phosphatases are required for both catalytic steps of pre-mRNA splicing.

Authors:  J E Mermoud; P Cohen; A I Lamond
Journal:  Nucleic Acids Res       Date:  1992-10-25       Impact factor: 16.971

Review 3.  The structure, role, and regulation of type 1 protein phosphatases.

Authors:  M Bollen; W Stalmans
Journal:  Crit Rev Biochem Mol Biol       Date:  1992       Impact factor: 8.250

Review 4.  Nuclear protein phosphorylation and growth control.

Authors:  D W Meek; A J Street
Journal:  Biochem J       Date:  1992-10-01       Impact factor: 3.857

Review 5.  Signal transduction from cell surface to nucleus in development and disease.

Authors:  M Karin
Journal:  FASEB J       Date:  1992-05       Impact factor: 5.191

6.  Phosphorylation of the phosphatase modulator subunit (inhibitor-2) by casein kinase-1. Identification of the phosphorylation sites.

Authors:  P Agostinis; O Marin; P James; P Hendrix; W Merlevede; J R Vandenheede; L A Pinna
Journal:  FEBS Lett       Date:  1992-06-29       Impact factor: 4.124

Review 7.  Casein kinase 2: an 'eminence grise' in cellular regulation?

Authors:  L A Pinna
Journal:  Biochim Biophys Acta       Date:  1990-09-24

8.  Rapid stimulation of Ser/Thr protein kinases following treatment of Swiss 3T3 cells with bombesin. Involvement of casein kinase-2 in the signaling pathway of bombesin.

Authors:  P Agostinis; J Van Lint; S Sarno; P De Witte; J R Vandenheede; W Merlevede
Journal:  J Biol Chem       Date:  1992-05-15       Impact factor: 5.157

9.  Phosphorylation of DARPP-32, a dopamine- and cAMP-regulated phosphoprotein, by casein kinase II.

Authors:  J A Girault; H C Hemmings; K R Williams; A C Nairn; P Greengard
Journal:  J Biol Chem       Date:  1989-12-25       Impact factor: 5.157

10.  Specificity of the polycation-stimulated (type-2A) and ATP,Mg-dependent (type-1) protein phosphatases toward substrates phosphorylated by P34cdc2 kinase.

Authors:  P Agostinis; R Derua; S Sarno; J Goris; W Merlevede
Journal:  Eur J Biochem       Date:  1992-04-01
View more
  9 in total

Review 1.  Endogenous inhibitor proteins that connect Ser/Thr kinases and phosphatases in cell signaling.

Authors:  Masumi Eto; David L Brautigan
Journal:  IUBMB Life       Date:  2012-07-20       Impact factor: 3.885

2.  The C-terminus of NIPP1 (nuclear inhibitor of protein phosphatase-1) contains a novel binding site for protein phosphatase-1 that is controlled by tyrosine phosphorylation and RNA binding.

Authors:  M Beullens; V Vulsteke; A Van Eynde; I Jagiello; W Stalmans; M Bollen
Journal:  Biochem J       Date:  2000-12-15       Impact factor: 3.857

Review 3.  Serine/threonine protein phosphatases.

Authors:  S Wera; B A Hemmings
Journal:  Biochem J       Date:  1995-10-01       Impact factor: 3.857

4.  Potentiation of neutrophil cyclooxygenase-2 by adenosine: an early anti-inflammatory signal.

Authors:  Jean-Sébastien Cadieux; Patrick Leclerc; Mireille St-Onge; Andrée-Anne Dussault; Cynthia Laflamme; Serge Picard; Catherine Ledent; Pierre Borgeat; Marc Pouliot
Journal:  J Cell Sci       Date:  2005-03-15       Impact factor: 5.285

5.  Structural basis for the recognition of regulatory subunits by the catalytic subunit of protein phosphatase 1.

Authors:  M P Egloff; D F Johnson; G Moorhead; P T Cohen; P Cohen; D Barford
Journal:  EMBO J       Date:  1997-04-15       Impact factor: 11.598

6.  The nuclear scaffold protein NIPP1 is essential for early embryonic development and cell proliferation.

Authors:  Aleyde Van Eynde; Mieke Nuytten; Mieke Dewerchin; Luc Schoonjans; Stefaan Keppens; Monique Beullens; Lieve Moons; Peter Carmeliet; Willy Stalmans; Mathieu Bollen
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

7.  Protein kinase CK2 modulates synaptic plasticity by modification of synaptic NMDA receptors in the hippocampus.

Authors:  Rie Kimura; Norio Matsuki
Journal:  J Physiol       Date:  2008-05-15       Impact factor: 5.182

Review 8.  Myosin light chain phosphatase: subunit composition, interactions and regulation.

Authors:  D J Hartshorne; M Ito; F Erdödi
Journal:  J Muscle Res Cell Motil       Date:  1998-05       Impact factor: 2.698

9.  Response to cAMP levels of the Epstein-Barr virus EBNA2-inducible LMP1 oncogene and EBNA2 inhibition of a PP1-like activity.

Authors:  R Fåhraeus; L Palmqvist; A Nerdstedt; S Farzad; L Rymo; S Laín
Journal:  EMBO J       Date:  1994-12-15       Impact factor: 11.598

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.